**Chapter 8**

*Human Blood Group Systems and Haemoglobinopathies*

[107] Pang Y, Xiao HW, Zhang H, Liu ZH, Li L, Gao Y, et al. Allogeneic bone marrow-derived mesenchymal stromal cells expanded In vitro for treatment of aplastic Anemia: A Multicenter phase II trial. Stem Cells Translational Medicine. 2017;**6**(7): 1569-1575. DOI: 10.1002/sctm.16-0227

[108] Clé DV, Santana-Lemos B, Tellechea MF, Prata KL, Orellana MD, Covas DT, et al. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia. Cytotherapy. 2015;**17**(12):1696-1705. DOI: 10.1016/j.jcyt.2015.09.006

[109] Kim HJ, Park J-S. Usage of human mesenchymal stem cells in cell-based therapy: Advantages and disadvantages.

Villanueva S, Khoury M. Mesenchymal stem cell treatment for autoimmune diseases: A critical review. Biological Research. 2012;**45**(3):269-277. DOI: 10.4067/S0716-97602012000300008

Mesenchymal stem cells as therapeutics.

[112] Fagioli F, Ferrero I. Mesenchymal stem cell manufacturing for clinical use. In: Progress in Stem Cell

Transplantation. Rijeka: InTechOpen;

[113] Erickson B, Nelson WP. Perspective

biotechnology in renewable chemicals. Biotechnology Journal. 2012;**7**:176-185.

Development & Reproduction. 2017;**21**(1):1-10. DOI: 10.12717/

[110] Figueroa FE, Carrión F,

[111] Parekkadan B, Milwid JM.

Annual Review of Biomedical Engineering. 2010;**12**(1):87-117. DOI: 10.1146/annurev-bioeng-070909-105309

2015. DOI: 10.5772/61370

on opportunities in industrial

DOI: 10.1002/biot.201100069

dr.2017.21.1.001

FOXP3/RORγt pathway. Scientific Reports. 2017;**7**:42488. DOI: 10.1038/

Vulliamy T, Dokal I, Marsh J, Dazzi F, et al. Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation. Leukemia. 2010;**24**:1791-1795. DOI: 10.1038/

[103] Yamei W, Rongmu L, Yongbin C, Yingjian S, Xiaohong L, Xiaomei Z, et al. Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning. Oncotarget. 2017;**8**(48):83817. DOI:

10.18632/oncotarget.19745

stem cells in haploidentical

DOI: 10.1038/bmt.2016.347

10.1007/s00277-018-3523-2

[106] Chen M, Zheng Z, He G, Lin S, Zhang D, Hu H, et al. Co-transplantation

of mesenchymal stem cells can ameliorates acute Gvhd and viremia after allogeneic hematopoietic stem cell transplantation for severe aplastic Anemia: A multi-Center retrospective

study of 119 patients. Blood.

blood-2018-99-118758

2018;**132**(1):4653-4653. DOI: 10.1182/

[104] Liu Z, Zhang Y, Xiao H, Yao Z, Zhang H, Liu Q, et al. Cotransplantation of bone marrow-derived mesenchymal

hematopoietic stem cell transplantation in patients with severe aplastic anemia: An interim summary for a multicenter phase II trial results. Bone Marrow Transplantation. 2017;**52**(5):704-710.

[105] Wang ZK, Yu HJ, Cao FL, Liu ZH, Liu ZY, Feng WJ, et al. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children. Annals of Hematology. 2019;**98**(2):473-479. DOI:

[102] Jaganathan BG, Tisato V,

srep42488

leu.2010.164

**166**
